Get started
Author

Veronica G. Anania

Observed names: Anania, Veronica, V Anania, V G Anania, V.G. Anania, VERONICA ANANIA, Veronica Anania, Veronica G Anania
Institution: Genentech
ORCID: 0000-0001-8758-2813
Observed ORCID: 0000-0001-8758-2813
OpenAlex ID: A5015350668
Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet
2023 · Cecilia Monteiro, Balazs Toth, et al. · Neurology · 116
PDF
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis
2024 · Anne H. Cross, Jeffrey M. Gelfand, et al. · JAMA Neurology · 104
PDF
Transcription Factor ATF4 Induces NLRP1 Inflammasome Expression during Endoplasmic Reticulum Stress
2015 · Andrea D’Osualdo, Veronica G. Anania, et al. · PLoS ONE · 62
PDF
An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens
2021 · Niclas Olsson, Marlene L. Heberling, et al. · Frontiers in Immunology · 30
PDF
Peptide Level Immunoaffinity Enrichment Enhances Ubiquitination Site Identification on Individual Proteins
2013 · Veronica G. Anania, Victoria C. Pham, et al. · Molecular & Cellular Proteomics · 29
Discovery and Qualification of Candidate Urinary Biomarkers of Disease Activity in Lupus Nephritis
2018 · Veronica G. Anania, Kebing Yu, et al. · Journal of Proteome Research · 24
Complementary Proteomic Tools for the Dissection of Apoptotic Proteolysis Events
2012 · Victoria C. Pham, Robert Pitti, et al. · Journal of Proteome Research · 24
SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML
2015 · Domenico Fasci, Veronica G. Anania, et al. · Science Signaling · 23
Combinatorial Approach for Large-scale Identification of Linked Peptides from Tandem Mass Spectrometry Spectra
2014 · Jian Wang, Veronica G. Anania, et al. · Molecular & Cellular Proteomics · 18
Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology
2024 · Stephen P. Schauer, Balazs Toth, et al. · Alzheimer s & Dementia · 15
PDF
Complementary Methods for the Identification of Substrates of Proteolysis
2014 · Victoria C. Pham, Veronica G. Anania, et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 14
Palmitoylation of MIR2 Is Required for Its Function
2010 · Veronica G. Anania, Laurent Coscoy · Journal of Virology · 12
Uncovering a Dual Regulatory Role for Caspases During Endoplasmic Reticulum Stress-induced Cell Death
2016 · Veronica G. Anania, Kebing Yu, et al. · Molecular & Cellular Proteomics · 11
A Novel Peptide-Based SILAC Method to Identify the Posttranslational Modifications Provides Evidence for Unconventional Ubiquitination in the ER-Associated Degradation Pathway
2013 · Veronica G. Anania, Daisy J. Bustos, et al. · International Journal of Proteomics · 11
PDF
Comprehensive profiling of the human fecal proteome from IBD patients with DIA‐MS enables evaluation of disease‐relevant proteins
2024 · Brandon J. Harder, Annemarie N. Lekkerkerker, et al. · PROTEOMICS - CLINICAL APPLICATIONS · 8
PDF
Surfactant protein D is a biomarker of influenza‐related pediatric lung injury
2021 · Arindam Chakrabarti, Allen Nguyen, et al. · Pediatric Pulmonology · 7
A Turn-Key Approach for Large-Scale Identification of Complex Posttranslational Modifications
2014 · Jian Wang, Veronica G. Anania, et al. · Journal of Proteome Research · 7
Development of an LC-MS/MS Method to Measure Sphingolipids in CSF from Patients with Multiple Sclerosis
2024 · Yadira X. Perez-Paramo, Dawn Dufield, et al. · Molecular Pharmacology · 6
PDF
SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab
2023 · Jeffrey L. Bennett, Kazuo Fujihara, et al. · Frontiers in Neurology · 6
PDF
Characterisation of the PK and PD of Satralizumab, a Recycling Antibody, to Support Q4W Dosing in Patients with NMOSD (1483)
2020 · Siân Lennon-Chrimes, Hanna Silber Baumann, et al. · Neurology · 6
CSF proteomics of semorinemab Alzheimer’s disease trials identifies cell-type specific signatures
2025 · Alyaa M Abdel-Haleem, Ellen Casavant, et al. · Brain · 4
Adolescents with NMOSD Achieved Similar Exposures and Favorable Safety Profile when Treated with the Adult Satralizumab Dosing Regimen (1492)
2020 · Cheryl Hemingway, Hanna Silber Baumann, et al. · Neurology · 4
Proteomic tools for the characterization of cell death mechanisms in drug discovery
2015 · Veronica G. Anania, Jennie R. Lill · PROTEOMICS - CLINICAL APPLICATIONS · 4
Editorial: Revolutionizing immunological disease understanding through single cell multi-omics technologies
2025 · Ying Zhu, Veronica G. Anania, et al. · Frontiers in Immunology · 3
PDF
Using SILAC to Develop Quantitative Data-Independent Acquisition (DIA) Proteomic Methods
2022 · Ellen P. Casavant, Jason Liang, et al. · Methods in molecular biology · 3
Works count: 50
Citation count: 560
H-index: 12
I10-index: 14
Year
Topic
Type